Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
29 déc. 2023 17h00 HE
|
Blueberries Medical Corp.
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Announces C$2 Million Non-Brokered Private Placement
15 déc. 2023 17h00 HE
|
Blueberries Medical Corp.
TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports Q1-2023
30 mai 2023 10h35 HE
|
Blueberries Medical Corp.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), a leading player in the cannabis industry...
Blueberries Medical Reports 2022 Financial Results
24 avr. 2023 16h18 HE
|
Blueberries Medical Corp.
TORONTO, April 24, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update
28 nov. 2022 17h00 HE
|
Blueberries Medical Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update
25 août 2022 17h51 HE
|
Blueberries Medical Corp.
TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture
29 juil. 2022 09h19 HE
|
Blueberries Medical Corp.
TORONTO, July 29, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update
30 mai 2022 17h23 HE
|
Blueberries Medical Corp.
TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Reports 2021 Financial Results
03 mai 2022 22h10 HE
|
Blueberries Medical Corp.
TORONTO, May 03, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update
29 nov. 2021 07h30 HE
|
Blueberries Medical Corp.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...